AnaptysBio: Funding, Investors & Team (Oct 2026)
AnaptysBio is a privately-owned company that specializes in therapeutic antibody products. They utilize somatic hypermutation (SHM) for discovering and enhancing antibodies, which is the body's natural way of creating strong antibodies to combat diseases. The company's SHM-Platform incorporates SHM and other methods to develop antibodies for therapeutic purposes through a process of natural evolution and high-throughput selection, known as naturalizing antibodies. This platform can be used to discover and enhance antibodies for specific disease targets, as well as improve existing antibodies' binding capabilities. It offers a more effective approach to antibody discovery and protein optimization, addressing a gap in the therapeutic antibody industry caused by acquisitions and licensing agreements that have limited access to technologies.
AnaptysBio has raised $100M across 1 funding round on record, the most recent an undisclosed round of $100M announced in Aug 2024.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
AnaptysBio Company Profile and Key Stats
Latest funding round on record: Aug 2024.
AnaptysBio Funding Rounds
AnaptysBio Founders and Leadership Team
No contact details are on record for this team yet.
AnaptysBio Funding Compared to Other Biotechnology Startups
AnaptysBio's latest round of $100M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like AnaptysBio in Biotechnology and San Diego
Companies Similar to AnaptysBio
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
AnaptysBio Funding FAQs
What does AnaptysBio do?
AnaptysBio is a privately-owned company that specializes in therapeutic antibody products. They utilize somatic hypermutation (SHM) for discovering and enhancing antibodies, which is the body's natural way of creating strong antibodies to combat diseases. The company's SHM-Platform incorporates SHM and other methods to develop antibodies for therapeutic purposes through a process of natural evolution and high-throughput selection, known as naturalizing antibodies. This platform can be used to discover and enhance antibodies for specific disease targets, as well as improve existing antibodies' binding capabilities. It offers a more effective approach to antibody discovery and protein optimization, addressing a gap in the therapeutic antibody industry caused by acquisitions and licensing agreements that have limited access to technologies.
How much funding has AnaptysBio raised?
AnaptysBio has raised $100M across 1 round on record. The most recent is an undisclosed round of $100M announced in Aug 2024.
When did AnaptysBio last raise funding?
AnaptysBio's most recent funding round on record is an undisclosed round of $100M, announced in Aug 2024.
Who founded AnaptysBio?
FundedIQ lists Andrew B. Cubitt (Founder) at AnaptysBio.
Where is AnaptysBio headquartered?
AnaptysBio is based in San Diego, California, United States.
How many employees does AnaptysBio have?
AnaptysBio is in the 101-250 employee band.
How does AnaptysBio's funding compare to other Biotechnology startups?
AnaptysBio's latest round of $100M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's AnaptysBio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for AnaptysBio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.